About
Therapeutic Botulinum Toxins
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
1,375
By Phase
PHASE2: 4
By Status
COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05016661Lead Sponsor
Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention
PHASE2Terminated
466 participants
Started: Oct 19, 2021 · Completed: Aug 30, 2024
NCT04871451Lead Sponsor
Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia
PHASE2Completed
51 participants
Started: Jul 27, 2021 · Completed: Jul 24, 2023
NCT04849988Lead Sponsor
A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia
PHASE2Completed
61 participants
Started: Mar 29, 2021 · Completed: Jul 11, 2022
NCT04845178Lead Sponsor
Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults
PHASE2Completed
797 participants
Started: Mar 1, 2021 · Completed: Aug 6, 2024
Locations (1)
Headquarters
Irvine, CA, United States
Map
Loading map...